PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1

Author:

Chen Zhiqiang12,Gao Wen3,Pu Liyong12,Zhang Long12,Han Guoyong12,Zuo Xueliang12,Zhang Yao12,Li Xiangcheng12,Shen Hongbing45,Wu Jindao124,Wang Xuehao12

Affiliation:

1. Department of Hepatobiliary Surgery; The First Affiliated Hospital of Nanjing Medical University; Nanjing China

2. Key Laboratory on Living Donor Liver Transplantation; National Health and Family Planning Commission; Nanjing China

3. Department of Oncology; The First Affiliated Hospital of Nanjing Medical University; Nanjing China

4. State Key Laboratory of Reproductive Medicine; Nanjing Medical University; Nanjing China

5. Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health; Nanjing Medical University; Nanjing China

Funder

National Natural Science Foundation of China

Fund of State Key Laboratory of Reproductive Medicine

Nanjing Medical University

Jiangsu Youth Medical Talents

Excellent Youth Teacher Support Program of Nanjing Medical University

Natural Science Foundation of Jiangsu Province

Six Talents Peak Project of Jiangsu Province

Jiangsu Province's Key Provincial Talents Program

333 High Class “Talented Man Project”

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3